HeartBeam, Inc. (BEAT) stock price, financials & research

Regular session · ET · Market data may be delayed.

GoAI snapshot

Jul 10, 2026

27/ 100

GoAI Score

Sell

Valuation

25

Expensive

Sentiment

51

Mixed

Risk

66

High Risk

Momentum

19

Strong Down

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

Company profile

Company website

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution. The device sends ECG signals to the patient's smartphone and on to a cloud-based software expert system. The company was founded by Branislav Vajdic in 2015 and is headquartered in Santa Clara, CA.

Industry: Medical - Specialties
Sector: Healthcare
Headquarters: US
CEO: Branislav Vajdic
Listed since: Nov 16, 2021
Employees: 16

Market position

Day range

Current $0.4064

$0.39$0.4207

52-week range

Current $0.4064

$0.39$4.00

Open: $0.42
Previous close: $0.4104
Volume: 271.58K; 0.4× average
Average volume: 686.04K; Average daily volume
Market cap: 22.56M USD
Beta: -0.8; Market reference 1
50-day average: $0.5323; -23.65% below average
200-day average: $1.1338; -64.16% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 76.52M USD
P/E (TTM): -0.78×
P/B (TTM): 2.62×
P/S (TTM): 0×
EV / EBITDA: -3.65×
Earnings yield: -25.98%
Free cash flow yield: -18.03%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 0.00%
Operating margin: 0.00%
Net margin: 0.00%
Return on equity: -807.34%
Return on assets: -359.66%
Return on invested capital: -812.10%

Financial health

Debt / equity: 0×
Current ratio: 1.45×
Altman Z-score: -11.33
Piotroski F-score: 2 of 9

Earnings

EPS beat rate: 36%; 4 beats, 7 misses, 0 met estimates
Average EPS surprise: -5.83%; 11 comparable reports
Latest EPS result: -0.1; Estimate -0.09 · Miss by 16.28%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$2.00

392.13% upside

Past 12 months12-month forecastHigh $2.00Average $2.00Low $2.00

Rating distribution

13 ratings

Strong buy00%

Buy969%

Hold431%

Sell00%

Strong sell00%

Recent analyst actions

3 institutions

D. Boral CapitalmaintainBuyMar 30, 2026

BEAT news

seekingalpha.comAug 14, 2026

HeartBeam, Inc. (BEAT) Q2 2026 Earnings Call Transcript

Read source

businesswire.comAug 13, 2026

HeartBeam Reports Second Quarter 2026 Results

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Reports Second Quarter 2026 Results.

Read source

businesswire.comJul 30, 2026

HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Second Quarter 2026 Results Conference Call on Thursday, August 13, 2026 at 4:30 p.m. Eastern Time.

Read source

zacks.comJul 16, 2026

Healthcare IT is the Next AI Growth Story: 3 Stocks to Buy Now

Healthcare IT is emerging as AI's next growth story as providers adopt AI to cut costs & improve care. Here we present three stocks that are likely to benefit.

Read source

gurufocus.comJul 14, 2026

HeartBeam Awarded New U.S. Patent Expanding Acoustic Sensing and Fluid Monitoring Capabilities of Its Cable-Free ECG Device

[url="]HeartBeam, Inc.[/url] (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today an

Read source